Exact Sciences Corporation (EXAS) Financials
Stock symbol EXAS is outdated, potentially delisted? Maybe it is available on other exchange?
EXAS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2025 | 5.9 billion | 3.5 billion |
| Sept. 30, 2025 | 5.9 billion | 3.4 billion |
| June 30, 2025 | 5.8 billion | 3.3 billion |
| March 31, 2025 | 5.7 billion | 3.3 billion |
EXAS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2025 | 120.4 million | 55.6 million |
| Sept. 30, 2025 | 190.0 million | 51.6 million |
| June 30, 2025 | 46.7 million | 55.8 million |
| March 31, 2025 | -365000 | 54.6 million |
EXAS Net Income
No data available :(
EXAS Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2025 | 964.7 million | 2.3 billion | 168.3 million |
| Sept. 30, 2025 | 1.0 billion | 2.3 billion | 171.7 million |
| June 30, 2025 | 858.4 million | 2.3 billion | 197.4 million |
| March 31, 2025 | 786.2 million | 2.3 billion | 198.7 million |
EXAS Shares Outstanding
EXAS Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2025 | 31.2 million | 191.5 million | 506.5 million | 288.5 million |
| Sept. 30, 2025 | 29.9 million | 117.3 million | 491.6 million | 250.2 million |
| June 30, 2025 | 42.3 million | 108.9 million | 455.7 million | 247.1 million |
| March 31, 2025 | 31.2 million | 105.3 million | 485.0 million | 264.3 million |
EXAS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2025 | 878.4 million | 262.6 million |
| Sept. 30, 2025 | 850.7 million | 266.8 million |
| June 30, 2025 | 811.1 million | 248.6 million |
| March 31, 2025 | 706.8 million | 206.2 million |
EXAS Revenue by Segment
Graph available only for paid members. Upgrade to see it.
EXAS
Price: $104.91
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.09 USD
P/E Ratio: -94.95
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 953316
Ebitda: -23.0 millionMarket Capitalization: 19.8 billion